EP Patent

EP1770603A1 — Encapsulated transponder and method for manufacturing the same

Assigned to Assa Abloy AB · Expires 2007-04-04 · 19y expired

What this patent protects

The invention concerns an encapsulated transponder (1) having an integrated circuit (2), an antenna (3) and one or more electrical connections (4) between the integrated circuit (2) and the antenna (3). At least the part of the transponder (1) comprising the electrical connection…

USPTO Abstract

The invention concerns an encapsulated transponder (1) having an integrated circuit (2), an antenna (3) and one or more electrical connections (4) between the integrated circuit (2) and the antenna (3). At least the part of the transponder (1) comprising the electrical connections (4) is embedded within a capsule (6) which is removable without damaging the electrical connections (4). Also claimed is a method for the production of a such transponder (1).

Drugs covered by this patent

Patent Metadata

Patent number
EP1770603A1
Jurisdiction
EP
Classification
—
Expires
2007-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Assa Abloy AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.